605 related articles for article (PubMed ID: 29273397)
21. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
22. The class II histone deacetylases as therapeutic targets for Parkinson's disease.
Mazzocchi M; Collins LM; Sullivan AM; O'Keeffe GW
Neuronal Signal; 2020 Jun; 4(2):NS20200001. PubMed ID: 32714601
[TBL] [Abstract][Full Text] [Related]
23. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
[TBL] [Abstract][Full Text] [Related]
24. Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform.
Chiu S; Terpstra KJ; Bureau Y; Hou J; Raheb H; Cernvosky Z; Badmeav V; Copen J; Husni M; Woodbury-Farina M
J Complement Integr Med; 2013 Nov; 10():. PubMed ID: 24200537
[TBL] [Abstract][Full Text] [Related]
25. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
Wang R; Sun H; Wang G; Ren H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
[TBL] [Abstract][Full Text] [Related]
26. [Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].
Qiao S; Luo JH; Jin JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):210-4. PubMed ID: 22499522
[TBL] [Abstract][Full Text] [Related]
27. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
[TBL] [Abstract][Full Text] [Related]
28. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
[TBL] [Abstract][Full Text] [Related]
29. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
Harrison IF; Anis HK; Dexter DT
Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
[TBL] [Abstract][Full Text] [Related]
30. Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T α-synuclein rat model of Parkinson's disease.
Musacchio T; Yin J; Kremer F; Koprich JB; Brotchie JM; Volkmann J; Ip CW
Behav Brain Res; 2022 Aug; 432():113968. PubMed ID: 35738338
[TBL] [Abstract][Full Text] [Related]
31. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.
Yakhine-Diop SMS; Niso-Santano M; Rodríguez-Arribas M; Gómez-Sánchez R; Martínez-Chacón G; Uribe-Carretero E; Navarro-García JA; Ruiz-Hurtado G; Aiastui A; Cooper JM; López de Munaín A; Bravo-San Pedro JM; González-Polo RA; Fuentes JM
Mol Neurobiol; 2019 Apr; 56(4):2466-2481. PubMed ID: 30032424
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein A53T Binds to Transcriptional Adapter 2-Alpha and Blocks Histone H3 Acetylation.
Lee JY; Kim H; Jo A; Khang R; Park CH; Park SJ; Kwag E; Shin JH
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065515
[TBL] [Abstract][Full Text] [Related]
33. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Shavali S; Combs CK; Ebadi M
Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
[TBL] [Abstract][Full Text] [Related]
34. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
35. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.
Toker L; Tran GT; Sundaresan J; Tysnes OB; Alves G; Haugarvoll K; Nido GS; Dölle C; Tzoulis C
Mol Neurodegener; 2021 May; 16(1):31. PubMed ID: 33947435
[TBL] [Abstract][Full Text] [Related]
37. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
Kontopoulos E; Parvin JD; Feany MB
Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795
[TBL] [Abstract][Full Text] [Related]
39. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
Ray A; Kambali M; Ravindranath V
Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
[TBL] [Abstract][Full Text] [Related]
40. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
